tiprankstipranks
Merrimack Pharmaceuticals Inc. (MACK)
NASDAQ:MACK
US Market

Merrimack Pharmaceuticals (MACK) Dividend Date & History

354 Followers
No upcoming dividends
Merrimack Pharmaceuticals has no upcoming dividends

Dividend Amount Per Share​

MACK Dividend Yield Range

MACK Dividend History

Ex-Date
Amount
Frequency
Declaration Date
Record Date
Payment Date
Dec 13, 2019$0.50Not AvailableDec 01, 2019Dec 16, 2019Dec 23, 2019
Sep 06, 2019$1.50Not AvailableAug 28, 2019Sep 05, 2019
May 30, 2017$10.55Not AvailableMay 18, 2017May 26, 2017
The table shows Merrimack Pharmaceuticals Inc.’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

Does Merrimack Pharmaceuticals Inc. pay dividends?
Yes, MACK has paid a dividend within the past 12 months.
    How much is Merrimack Pharmaceuticals Inc.'s dividend?
    Merrimack Pharmaceuticals Inc. (MACK) does not pay a dividend
    When is Merrimack Pharmaceuticals Inc. ex-dividend date?
    Merrimack Pharmaceuticals's previous ex-dividend date was on Dec 13, 2019. Merrimack Pharmaceuticals shareholders who own MACK stock before this date received Merrimack Pharmaceuticals's last dividend payment of $0.5 per share on Dec 23, 2019. MACK's next ex-dividend date has not been announced yet.
      When is Merrimack Pharmaceuticals Inc. dividend payment date?
      Merrimack Pharmaceuticals’s next quarterly payment date is on Dec 23, 2019, when Merrimack Pharmaceuticals shareholders who owned MACK shares before Dec 13, 2019 received a dividend payment of $0.5 per share. Add MACK to your watchlist to be reminded of MACK's next dividend payment.
        Does Merrimack Pharmaceuticals Inc. have sufficient earnings to cover their dividend?
        Merrimack Pharmaceuticals Inc. (MACK) does not pay a dividend.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis